Top 50 Clinical Trial Platform in Asia

Yonalink provides an AI-powered platform that streams clinical trial data in real time from electronic health records (EHRs) to electronic data capture (EDC) systems, significantly reducing manual data entry and associated errors. This solution enhances data quality and operational efficiency for clinical trial sponsors, contract research organizations (CROs), and hospitals by automating data transfer and management processes.

QuantHealth utilizes a proprietary AI platform to conduct patient-centric drug simulations, enabling pharmaceutical and biotech companies to run extensive variations of clinical trials. This approach addresses the high failure rate of drugs in development, significantly increasing the probability of trial success and facilitating the discovery of new clinical opportunities.

Quris offers a Bio-AI Clinical Prediction Platform that utilizes machine learning trained on miniaturized Patients-on-a-Chip to predict the safety of drug candidates in humans. This approach aims to reduce the high failure rate of clinical trials, which currently sees 89% of drugs not making it to market, thereby lowering development costs.

Beaconcure offers Verify, an automated solution utilizing machine learning and natural language processing for the validation of clinical trial statistical outputs. This technology enhances data accuracy and accelerates regulatory approval processes, enabling faster market entry for new drugs and vaccines.

Axonvertex AI offers a private, on‑premise AI engineering platform for healthcare and clinical‑trial organizations, enabling secure execution of large language and tiny models with built‑in NIST‑aligned responsible‑AI safeguards, human‑in‑the‑loop controls, and FHIR‑based data integration. The platform provides auditable AI agents and edge inference to support compliant decision‑support and workflow automation while keeping patient data local.

QuantHealth provides next-generation clinical AI for drug-patient simulations to guide clinical development decisions. The platform integrates biomedical, clinical, and epidemiological data into a unified framework for deep analysis. This enables optimization across clinical development, business development, and portfolio management use cases.

This company likely develops artificial intelligence solutions tailored for the healthcare sector. Their focus is on leveraging machine learning for applications such as diagnostics, patient management, or operational efficiency within medical systems. The core value proposition centers on integrating advanced AI technology to improve clinical outcomes and administrative processes in healthcare delivery.

Pharmides offers a cloud‑native platform that consolidates pre‑clinical, clinical and manufacturing data into a single, auditable environment, automating GMP/GLP documentation, change‑control workflows and electronic signatures. The system provides real‑time KPI dashboards, AI‑driven predictive analytics and bi‑directional REST APIs to integrate with LIMS, ERP and ELN systems, ensuring compliance with FDA 21 CFR Part 11 and EMA Annex 11. End‑to‑end encryption and immutable audit logs support secure, versioned records for pharma manufacturers, biotech R&D and CMOs.

The Healthy Billion utilizes big data analytics and clinical intelligence to generate real-world clinical evidence and insights from extensive healthcare datasets, enhancing patient care and engagement. By providing healthcare enterprises with a 360-degree care engine, the startup enables hyper-personalized experiences and improves operational efficiency across various disease conditions and patient segments.

Mabwell Biotech develops biologic drugs through a comprehensive research and development framework that includes antibody target discovery, preclinical studies, and clinical trials. The company addresses unmet clinical needs by providing effective and accessible biopharmaceuticals for patients worldwide.

Axelium automates meta-analyses for healthcare, biotech, pharma, CRO, and market access industries using machine learning. This platform streamlines the process of synthesizing research data, enabling faster and more efficient evidence generation for clinical and commercial decision-making.

Tongtongeyan develops clinical research databases tailored for medical professionals, utilizing structured data management and analytics to enhance research efficiency. The platform addresses the challenge of fragmented data collection in clinical studies, enabling streamlined access to critical information and improved decision-making.

UProtech is a protac platform focused on developing targeted protein degradation therapies for cancer and autoimmune diseases. The company utilizes a comprehensive drug development technology platform that includes small molecule design and clinical trial support to create effective treatments for challenging drug targets.

Beyond Therapeutics utilizes its ExCEED technology to accelerate the discovery and development of new medications targeting unmet therapeutic needs. This platform enhances the efficiency of drug development processes, reducing time-to-market for critical treatments.

Xilingyuan Pharmaceutical utilizes advanced computational modeling and data analytics to streamline the drug development process, significantly reducing time-to-market for new therapeutics. The company addresses the inefficiencies and high costs associated with traditional drug discovery methods, enabling faster and more cost-effective solutions for pharmaceutical innovation.

The startup develops immune cell preparations and application technologies specifically designed for cancer patients, enhancing the efficacy of immunotherapy treatments. By focusing on personalized medicine, the company aims to improve patient outcomes and quality of life through targeted therapeutic interventions.

The startup utilizes artificial intelligence and big data analytics to enhance drug discovery and development for cancers and rare diseases. Their in-house research facility focuses on accelerating the identification of effective treatments, addressing the lengthy and costly process of bringing new drugs to market.

This platform provides an AI advocate to help patients and caregivers manage complex health journeys by integrating and interpreting personal medical records. It offers tools to understand health history, prepare for appointments, and draft necessary administrative documents. The service also facilitates secure, de-identified data sharing to advance rare disease research.

Lavaa Health provides an AI-powered clinical intelligence platform that integrates with EMR systems to deliver real-time patient risk assessments and care gap identification. This platform streamlines workflows and automates outreach to enable proactive, preventive care management for healthcare teams. The resulting value includes improved clinical outcomes, reduced hospitalizations, and optimized financial performance through better revenue capture.

CollectiveGood operates a platform that utilizes a network of clinical experts to provide consensus assessments of medical AI performance through continuous testing and human evaluation. This approach addresses the need for reliable validation of AI models in healthcare, ensuring their effectiveness and safety in real-world applications.

The startup develops a regenerative medicine platform that integrates clinical data and health sciences research to create new medical technologies. This platform provides a centralized resource for advancing healthcare solutions tailored to specific clinical needs.

Pasbox utilizes artificial intelligence to analyze molecular biology data, providing healthcare solutions that enhance patient outcomes. The platform addresses inefficiencies in data interpretation and decision-making in clinical settings, enabling faster and more accurate diagnostics.

1Cell provides an AI-powered single‑cell liquid biopsy platform that isolates circulating tumor cells and generates multi‑omics profiles in real time. The system combines high‑throughput cell capture hardware with machine‑learning analytics to deliver molecular signatures for early cancer detection, therapy response prediction, and disease monitoring.

Medsynapse is an online platform that connects over 1.5 million healthcare professionals across more than 100 countries, facilitating secure communication and collaboration on clinical cases through HIPAA-compliant messaging. By providing real-time access to medical updates, clinical guidelines, and continuing medical education (CME) resources, Medsynapse enhances decision-making and improves patient outcomes in a complex healthcare landscape.

Medcase provides a platform that connects healthcare organizations with a global network of clinicians across various specialties, facilitating telehealth services and clinical staffing in over 30 countries. This solution addresses the challenge of accessing qualified healthcare professionals efficiently, enabling organizations to enhance patient care and streamline operational workflows.

Qlife Lab provides clinical mass spectrometry solutions that integrate omics research, diagnostic reagents, and third-party medical testing to enhance precision medicine. Their high-throughput qULTRA® platform enables the discovery and validation of novel biomarkers, addressing the gap in technology transfer within life sciences research.

TXP Medical develops integrated medical data systems that utilize cloud-based platforms and AI-driven voice input applications to streamline patient information management in emergency and intensive care settings. The company addresses the fragmentation of medical data, which leads to inefficiencies and delays in patient care, by enabling seamless data sharing between healthcare providers and empowering patients with access to their own medical information.

THB is a healthcare data-technology platform that utilizes big data analytics to generate real-world clinical evidence and enhance patient care through a 360-degree Care Engine. By processing over 1 billion clinical parameters, THB enables healthcare enterprises to deliver hyper-personalized treatment recommendations and improve decision-making for over 20 million patients.

Medframe provides a platform for the collection, structuring, and delivery of anonymized medical data from diverse sources, including EHR and imaging systems, using AI for efficient data organization. This enables healthcare researchers and organizations to access reliable, tailored datasets quickly, enhancing the accuracy and relevance of their studies while adhering to stringent data protection standards.

KS Bitusen is a drug research and development company focused on creating therapies for muscle diseases, particularly sarcopenia, which significantly impacts the quality of life in the aging population. Utilizing over 30 years of expertise in muscle research, the company aims to advance clinical trials and develop effective treatments in a market currently lacking viable options.

The startup provides an interactive educational platform featuring virtual patient simulations that enable medical students to practice clinical skills in a risk-free environment. This platform addresses the gap in hands-on experience during medical training by allowing students to engage in realistic diagnosis and treatment scenarios.

The startup operates a healthcare platform that integrates health data analytics with AI-driven tools to enhance clinical decision-making and optimize patient management. By streamlining administrative processes, the platform enables healthcare providers to deliver personalized care more efficiently, improving patient outcomes and operational performance.

KaiFu Pharmaceuticals develops small molecule drugs using an affinity detection by mass spectroscopy (ADMS) platform to identify and optimize compounds for treating tumors and autoimmune diseases. Their lead candidates, KF-0210 and KBP-2205, target unmet medical needs in oncology and have advanced to clinical trial stages, providing potential new therapies for patients.

The startup develops a remote management platform that utilizes artificial intelligence, the Internet of Things, and predictive analytics to provide real-time clinical decision support. This technology enhances patient monitoring and early-stage diagnosis of critical diseases, aiming to improve outcomes and reduce neonatal mortality rates.

CytoReason develops a cell-centered computational model that analyzes biological data to map disease mechanisms and treatment effects. This technology enables pharmaceutical companies to prioritize drug development and make data-driven decisions by providing insights into drug performance across diverse patient populations.

Modelife AI develops advanced machine learning models tailored for predictive analytics in the life sciences sector. The platform processes complex genomic and clinical datasets to accelerate drug discovery pipelines and optimize therapeutic development. This specialized AI infrastructure provides researchers with actionable insights to improve trial efficiency and patient stratification.

The startup provides a Diagnostics-as-a-Service platform that enables insurers, health plans, and direct-to-consumer brands to implement scalable health check programs using a network of over 1,000 accredited labs. This solution addresses the need for efficient, automated diagnostic testing and data management, enhancing patient engagement and improving health outcomes through real-time insights and streamlined logistics.

TechnoDerma Medicines is developing topical pharmaceuticals targeting skin conditions such as androgenetic alopecia and atopic dermatitis, utilizing JAK1/TYK2 inhibitors and small molecule compounds. Their clinical trials aim to demonstrate the efficacy and safety of these treatments, addressing the unmet medical needs of patients suffering from these dermatological disorders.

Villanelle Life develops AI-driven platforms for drug discovery, early disease screening, and diagnostic support. Their technology aims to accelerate the identification of potential drug candidates and improve disease detection and diagnosis.

Acornmed provides clinical oncology solutions through data analytics and decision support tools that integrate patient data with evidence-based guidelines. This platform enhances treatment planning and patient management, improving clinical outcomes in personalized cancer care.

Thakaa Med utilizes artificial intelligence to analyze patient data and optimize treatment plans, enhancing clinical decision-making in healthcare settings. The platform addresses inefficiencies in patient management and care coordination, leading to improved health outcomes and reduced operational costs for providers.

Kahun is a medical evidence-based clinical reasoning engine that utilizes a mapped medical knowledge database to assist healthcare professionals in diagnosing and treating patients more effectively. By providing instant access to relevant clinical data, Kahun enhances decision-making and improves patient outcomes in complex medical scenarios.

Provides a blockchain-based platform that enables secure, compliant sharing and monetization of personal health data between patients, healthcare providers, and life science companies. This system streamlines post-market research, patient engagement, and real-world evidence generation, improving cohort identification, treatment adherence, and market access for novel therapies.

The startup operates a digital platform that integrates artificial intelligence and big data analytics to create a structured repository of patient clinical data and longitudinal health histories. This technology enhances healthcare delivery by providing organizations with actionable insights, improving patient engagement and continuity of care across various interventions and services.

The startup offers a healthcare optimization platform that utilizes data analytics to identify at-risk patients and recommend timely interventions based on their unique health journeys. By providing healthcare organizations with personalized patient data and actionable insights, the platform enhances clinical outcomes and financial performance in value-based care models.

This startup specializes in drug discovery by developing botanical medicines and therapeutics from natural compounds, utilizing cannabis molecular analysis and pre-clinical trials. It enables researchers to evaluate the efficacy of cannabis and psilocybin extracts on various cell line models, facilitating the integration of botanical medicine into the pharmaceutical industry.

PURMX Therapeutics develops RNA-based nucleic acid drugs, specifically targeting malignant pleural mesothelioma through its proprietary functional RNA screening platform. The company aims to provide effective therapies for patients with intractable cancers by utilizing small ribonucleic acids to eliminate cancer cells.

The startup has developed a healthcare technology platform that connects patients with eligible clinical trials, facilitating direct communication between patients and pharmaceutical companies. This platform enhances patient engagement and ensures that health information is effectively shared with medical professionals, improving trial participation and patient understanding of health outcomes.

The startup develops a medical data platform that integrates real-time healthcare data through an interoperable network, enabling efficient management of clinical practice data. This platform provides tailored statistical analysis, allowing health professionals and patients to access and utilize their health information effectively.

Lind is a precision trial matching platform that utilizes AI to analyze electronic health records and generate personalized matches with over 85,000 active clinical trials based on individual medical histories. This technology enables patients to quickly identify relevant treatment options, facilitating access to innovative therapies for conditions such as cancer and diabetes.